neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer
13 Dec 2016
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer
No benefit for adjuvant ibandronate at 3 years in early breast cancer
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer
Matched mutations in the progression of metastatic breast cancer
Barriers to oncology information access in Ireland
The México Salud-Hable coalition
Patient empowerment and engagement
Cancer care in North Africa
The NCD Alliance
UN joint program on cervical cancer prevention and control
Health, equity and womens cancers